Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Barakat

Showing results (331-340 of 402) with videos related to

Pageof 41
Sort By:
Gynecologic Oncology|September 26, 2006
CA125 level as a predictor of progression-free survival and overall survival in ovarian cancer patients with surgically defined disease status prior to the initiation of intraperitoneal consolidation therapyMargrit M Juretzka, Richard R Barakat, Dennis S Chi, et al.
Gynecologic Oncology|December 23, 2008
A contemporary analysis of the ability of preoperative serum CA-125 to predict primary cytoreductive outcome in patients with advanced ovarian, tubal and peritoneal carcinomaDennis S Chi, Oliver Zivanovic, Meena J Palayekar, et al.
Gynecologic Oncology|August 12, 2009
Exploratory analysis of serum CA-125 response to surgery and the risk of relapse in patients with FIGO stage IIIC ovarian cancerOliver Zivanovic, Camelia S Sima, Alexia Iasonos, et al.
Gynecologic Oncology|September 11, 2013
Intraoperative hypothermia during primary surgical cytoreduction for advanced ovarian cancer: risk factors and associations with postoperative morbidityKara C Long, Edward J Tanner, Melissa Frey, et al.
Gynecologic Oncology|January 19, 2016
Herniation formation in women undergoing robotically assisted laparoscopy or laparotomy for endometrial cancerMaria B Schiavone, Maciej S Bielen, Ginger J Gardner, et al.
Gynecologic Oncology|December 1, 2009
Video-assisted thoracic surgery (VATS) evaluation of pleural effusions in patients with newly diagnosed advanced ovarian carcinoma can influence the primary management choice for these patientsJohn P Diaz, Nadeem R Abu-Rustum, Yukio Sonoda, et al.
Gynecologic Oncology|December 17, 2009
Incidence and management of bevacizumab-associated gastrointestinal perforations in patients with recurrent ovarian carcinomaJohn P Diaz, William P Tew, Oliver Zivanovic, et al.
Cancer|March 31, 2006
Guidelines and selection criteria for secondary cytoreductive surgery in patients with recurrent, platinum-sensitive epithelial ovarian carcinomaDennis S Chi, Kristina McCaughty, John P Diaz, et al.
Gynecologic Oncology|October 9, 2013
Sentinel lymph node mapping with pathologic ultrastaging: a valuable tool for assessing nodal metastasis in low-grade endometrial cancer with superficial myoinvasionChristine H Kim, Fady Khoury-Collado, Emma L Barber, et al.
Gynecologic Oncology|December 22, 2009
The effect of primary cytoreduction on outcomes of patients with FIGO stage IIIC ovarian cancer stratified by the initial tumor burden in the upper abdomen cephalad to the greater omentumOliver Zivanovic, Camelia S Sima, Alexia Iasonos, et al.
Pageof 41

Showing results (331-340 of 402) with videos related to

Sort By:
Pageof 41
Gynecologic Oncology|September 26, 2006
CA125 level as a predictor of progression-free survival and overall survival in ovarian cancer patients with surgically defined disease status prior to the initiation of intraperitoneal consolidation therapyMargrit M Juretzka, Richard R Barakat, Dennis S Chi, et al.
Gynecologic Oncology|December 23, 2008
A contemporary analysis of the ability of preoperative serum CA-125 to predict primary cytoreductive outcome in patients with advanced ovarian, tubal and peritoneal carcinomaDennis S Chi, Oliver Zivanovic, Meena J Palayekar, et al.
Gynecologic Oncology|August 12, 2009
Exploratory analysis of serum CA-125 response to surgery and the risk of relapse in patients with FIGO stage IIIC ovarian cancerOliver Zivanovic, Camelia S Sima, Alexia Iasonos, et al.
Gynecologic Oncology|September 11, 2013
Intraoperative hypothermia during primary surgical cytoreduction for advanced ovarian cancer: risk factors and associations with postoperative morbidityKara C Long, Edward J Tanner, Melissa Frey, et al.
Gynecologic Oncology|January 19, 2016
Herniation formation in women undergoing robotically assisted laparoscopy or laparotomy for endometrial cancerMaria B Schiavone, Maciej S Bielen, Ginger J Gardner, et al.
Gynecologic Oncology|December 1, 2009
Video-assisted thoracic surgery (VATS) evaluation of pleural effusions in patients with newly diagnosed advanced ovarian carcinoma can influence the primary management choice for these patientsJohn P Diaz, Nadeem R Abu-Rustum, Yukio Sonoda, et al.
Gynecologic Oncology|December 17, 2009
Incidence and management of bevacizumab-associated gastrointestinal perforations in patients with recurrent ovarian carcinomaJohn P Diaz, William P Tew, Oliver Zivanovic, et al.
Cancer|March 31, 2006
Guidelines and selection criteria for secondary cytoreductive surgery in patients with recurrent, platinum-sensitive epithelial ovarian carcinomaDennis S Chi, Kristina McCaughty, John P Diaz, et al.
Gynecologic Oncology|October 9, 2013
Sentinel lymph node mapping with pathologic ultrastaging: a valuable tool for assessing nodal metastasis in low-grade endometrial cancer with superficial myoinvasionChristine H Kim, Fady Khoury-Collado, Emma L Barber, et al.
Gynecologic Oncology|December 22, 2009
The effect of primary cytoreduction on outcomes of patients with FIGO stage IIIC ovarian cancer stratified by the initial tumor burden in the upper abdomen cephalad to the greater omentumOliver Zivanovic, Camelia S Sima, Alexia Iasonos, et al.
Pageof 41